Zhengye Biotechnology Holding Limited (ZYBT)
Zhengye Biotechnology Holding will go public soon, but the exact IPO date is still unknown.
IPO Price Range
$4.00 - $5.00
Shares Offered
1,250,000
Deal Size
$5.63M
Company Description
Zhengye Biotechnology Holding, through its operating entity, focus on the research, development, manufacturing and sales of veterinary vaccines, with an emphasis on vaccines for livestock.
For nearly 20 years, the operating entity has been committed to enhancing the health of livestock by offering a diverse range of vaccines, including vaccines for swine, cattle, goats, sheep, poultry, and dogs.
The operating entity’s products are available in 29 provincial regions across China and are exported overseas, to Vietnam, Pakistan, and Egypt.
Zhengye Biotechnology Holding Limited
| Country | China |
| Founded | 2004 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 299 |
| CEO | Songlin Song |
Contact Details
Address: No.1 Lianmeng Road, Jilin Economic & Technical Development Zone Jilin City, Jilin Province China | |
| Phone | +86-0432-63047008 |
| Website | jlzybio.com |
Stock Details
| Ticker Symbol | ZYBT |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| CIK Code | 0001975641 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Zhenfa Han | Director and Chairman of the Board |
| Songlin Song | Chief Executive Officer |
| Wenhua Sun | Director |
| Ping Wang | Chief Financial Officer |
| Zhongyao Liu | Vice General Manager |
| Wei Lian | Vice General Manager |
| Yawen Dong | Vice General Manager |
| Yuyou He | Vice General Manager |
| Wanlin Zhang | Vice General Manager |
| Yuhong Cheng | Vice General Manager |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 27, 2024 | FWP | Free Writing Prospectus |
| Jun 21, 2024 | FWP | Free Writing Prospectus |
| Jun 14, 2024 | F-1/A | [Amend] Registration statement for certain foreign private issuers |
| May 15, 2024 | F-1/A | [Amend] Registration statement for certain foreign private issuers |
| Jan 9, 2024 | F-1 | Registration statement for certain foreign private issuers |
| Dec 14, 2023 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| Nov 17, 2023 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| Sep 28, 2023 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| Aug 4, 2023 | DRS | [Cover] Draft Registration Statement |